COMMUNIQUÉS West-GlobeNewswire

Immunomedics Announces Closing of Public Offering of Common Stock
15/06/2018
MORRIS PLAINS, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Grant of Warrants
15/06/2018
June 15, 2018 Announcement no. 11 In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the Articles of Association, the Board of Directors of BioPorto A/S [...]
Nohla Announces Presentation of Dilanubicel (NLA101) Data at EHA Annual Meeting Showcasing Excellent Long-term Survival Outcomes
15/06/2018
Compelling Evidence of Rapid Immune Recovery and Improved Long-Term Outcomes After Hematopoietic Stem Cell Transplant SEATTLE, June 15, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off- [...]
Hemispherx Releases First 8,500 Vial Lot of Ampligen to Supply Expanded Access Programs in the United States, Europe and Canada for ME/CFS and Pancreatic Cancer and Announces Successful Finish of Second Commercial Size Lot
15/06/2018
Balance for New Cancer Clinical Trials; Second Commercial-Size Batch Now in Regulatory Testing ORLANDO, Fla., June 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) has announced the successful [...]
Analogic Introduces Its Newest RF Amplifier for 1.5 Tesla MRI Systems
15/06/2018
PEABODY, Mass., June 15, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, has announced the release of the AN8150-01 1.5T 20 kW RF [...]
Sienna Announces June Dividend
15/06/2018
MARKHAM, Ontario, June 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX:SIA) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]
TG Therapeutics, Inc. Announces Clinical and Preclinical Data Presentations at the 23rd Congress of the European Hematology Association
15/06/2018
NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the presentation of an integrated analysis of long term safety data of umbralisib (TGR-1202), the Company’s PI3K delta [...]
Polydex Pharmaceuticals Issues First Quarter Financial Results
15/06/2018
Continued Profitability and Increased Unit Sales in U.S. TORONTO, June 15, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of [...]
CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of Base Material of its PlusCBD Oil™ Products
15/06/2018
LAS VEGAS, June 15, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today the June 7, 2018 publication of the toxicology and safety results of an extract [...]
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
15/06/2018
New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) [...]
Stemline Therapeutics Announces Presentation of ELZONRIS™ (tagraxofusp; SL-401) Preclinical Data in Systemic Sclerosis, an Autoimmune Disorder, at EULAR Congress
15/06/2018
NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that ELZONRIS™ (tagraxofusp; SL- [...]
TG Therapeutics, Inc. Announces Oral Presentation of Umbralisib plus Ruxolitinib in Patients with Myelofibrosis at the 23rd Congress of the European Hematology Association
15/06/2018
Data demonstrates that the addition of umbralisib to ruxolitinib can induce responses in patients with sub-optimal response to ruxolitinib single agent NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. ( [...]
Akari Therapeutics to Present Poster at the 23rd Congress of the European Hematology Association
15/06/2018
NEW YORK and LONDON, June 15, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan [...]
Insmed Announces FDA Advisory Committee Meeting to Review ALIS as a treatment for NTM Lung Disease Caused by MAC
15/06/2018
Meeting planned for August 7, 2018 BRIDGEWATER, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, [...]
Extendicare Announces June 2018 Dividend of C$0.04 per Share
15/06/2018
MARKHAM, Ontario, June 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share [...]
Aptose Presents New CG-806 Data at the 23rd Congress of the European Hematology Association
15/06/2018
CG-806 Continues to Demonstrate Superior Activity to Ibrutinib BTK Inhibitor STOCKHOLM, Sweden and SAN DIEGO, June 15, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the [...]
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
15/06/2018
Study completion and submission of 510(k) notification expected in Calendar Q3 2018 FRAMINGHAM, Mass., June 15, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of [...]
Summit Therapeutics to Present at the JMP Securities Life Sciences Conference
15/06/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics to Present at the JMP Securities Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 15 June 2018 - Summit Therapeutics plc (NASDAQ: SMMT [...]
AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry®
15/06/2018
Transaction Underscores AMAG’s Focus on Clinical Development and Commercialization of Pharmaceuticals Company Intends to Use the Majority of Proceeds to Pay off High-Yield Debt WALTHAM, Mass., June 15, 2018 (GLOBE [...]

Pages